ABOUT US
Lysine Biotech is a state-of-the-art start-up biotech company located in Sri Ramachandra Innovation and Incubation Centre (SRIIC), Porur TN. Chennai, India.
The company was established during the year 2018 by Managing Director and eminent scientist Dr. AnandaGopu PERUMAL with great ambition.
The SRIIC has a state-of-the-art common Sophisticated Instrumentation Laboratory: A Centralized instrumentation facility housing high end equipment and facilities including Next Generation Sequencing, cell biology, proteomics, analytical instruments etc.,
The SRIIC has a state-of-the-art GLP Accredited Animal Experimentation Facility: The facility is registered with CPCSEA, GoI, (189/PO/ReBi/S/2000/CPCSEA) and falls under the Animal Bio Safety level II (ABSL II) and is an OECD-GLP compliant Test facility (GLP/C-105/2017). Studies are conducted according to the regulatory test guidelines viz; FDA, EMEA, ICH, CDSCO, DCGI, Schedule, ISO etc with prior approval from institutional animal ethics committee.
The SRIIC has a state-of-the-art Clinical Trials Facility: The facility is frequently audited by DCGI and supported by the NABH accredited hospital infrastructure and NABL accredited laboratory services for clinical research. Studies are conducted in diverse medical fields including cardiology, pulmonology, oncology, surgery, endocrinology, reproductive medicine, psychiatry, etc.
Strong capabilities in new scientific platforms including Small molecules based drugs delivery (IND), 2nd,3rd,4th & 5th generation of CAR T cell, Dentritic cells, NK cells, mRNA based gene therapies, Vaccine and Biobetter Insoluble drug delivery technologies, Antimicrobial drug resistance bi & tri specific antibiotics, antifungal and antibody conjugates, and Industrial (Chemicals and Enzymes).
Lysine Biotech has occupied more than 1500 sqft. Ft with the state-of-the-art infrastructure and instruments and located in Sri Ramachandra Innovation and Incubation Centre (SRIIC), Porur TN. Chennai, India.
Who We Are
Lysine Biotech is a start-up biotech company based in Tamilnadu, India and established in the year 2018.
We are currently involved in new Small molecules based drugs delivery (IND), 2nd,3rd,4th & 5th generation of CAR T cell, Dentritic cells, NK cells and mRNA based Gene Therapy, Biosimilar and vaccine from Discovery stage and Early process development through pre-clinical and human clinical trials.
In addition to drug/vaccine discovery and development related to infectious diseases, we have also made contributions to projects in Diabetes, Oncology, Cardiovascular, Neuroscience and Rare diseases.
Our aim is to provide affordable, Efficacy, Safety, Safe and Efficient drugs, CAR T cell, mRNA basd gene therapy and vaccines for human and animal against diseases with global prevalence.
Meet The Team

Managing Director
Email to panandagopu@lysinebiotech.com

Sales Team
Email to sales@lysinebiotech.com

Customer Support
Email to support@lysinebiotech.com